Projected incremental cost effectiveness ratios of potential interventions to improve HCV follow-up.

<p>QALY = Quality-adjusted life year; ICER = incremental cost-effectiveness ratio.</p><p>Costs and QALYs are lifetime and discounted at an annual rate of 3%. Costs are in 2011 U.S.$ and rounded to the nearest $100. All QALYs are rounded to the nearest hundredth.</p>a<p>The ICER of linkage compared to standard of care is $26,500/QALY gained; linkage is extended dominated.</p>b<p>The ICER of treatment initiation compared to standard of care is $19,200/QALY gained; treatment initiation is extended dominated.</p>c<p>The ICER of peer navigators compared to standard of care is $20,000/QALY gained.